nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—GNRHR—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.0216	0.197	CbGpPWpGaD
Goserelin—Pentagastrin—BCHE—peripheral nervous system neoplasm	0.0102	1	CrCbGaD
Goserelin—LHCGR—Arf6 signaling events—HGF—peripheral nervous system neoplasm	0.00816	0.0746	CbGpPWpGaD
Goserelin—LHCGR—Arf6 signaling events—MET—peripheral nervous system neoplasm	0.00644	0.0589	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00601	0.0549	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00382	0.0349	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00378	0.0346	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00342	0.0312	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00311	0.0285	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00288	0.0263	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00276	0.0252	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00253	0.0231	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00193	0.0176	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00185	0.0169	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00172	0.0157	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.0017	0.0155	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00163	0.0149	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00153	0.014	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00148	0.0135	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00142	0.0129	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00129	0.0118	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00123	0.0113	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00114	0.0104	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00113	0.0103	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00112	0.0102	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00109	0.00996	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00103	0.00945	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000988	0.00904	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000948	0.00867	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000933	0.00853	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000872	0.00798	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000865	0.00792	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000836	0.00765	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000825	0.00754	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000757	0.00692	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000749	0.00685	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000731	0.00668	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000691	0.00632	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000663	0.00607	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000661	0.00605	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000639	0.00584	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00061	0.00558	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000584	0.00534	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00058	0.00531	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000561	0.00513	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00056	0.00512	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000489	0.00447	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000458	0.00419	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000444	0.00406	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000443	0.00405	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000428	0.00391	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.00041	0.00375	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000408	0.00374	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000403	0.00369	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000392	0.00358	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000388	0.00355	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000374	0.00342	CbGpPWpGaD
Goserelin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000371	0.000422	CcSEcCtD
Goserelin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00037	0.000421	CcSEcCtD
Goserelin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000419	CcSEcCtD
Goserelin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000369	0.000419	CcSEcCtD
Goserelin—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000416	CcSEcCtD
Goserelin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000413	CcSEcCtD
Goserelin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000364	0.000413	CcSEcCtD
Goserelin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000362	0.000411	CcSEcCtD
Goserelin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000411	CcSEcCtD
Goserelin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000361	0.00041	CcSEcCtD
Goserelin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.000409	CcSEcCtD
Goserelin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000356	0.000405	CcSEcCtD
Goserelin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000356	0.000404	CcSEcCtD
Goserelin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000399	CcSEcCtD
Goserelin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.000398	CcSEcCtD
Goserelin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000397	CcSEcCtD
Goserelin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000395	CcSEcCtD
Goserelin—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000394	CcSEcCtD
Goserelin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000347	0.000394	CcSEcCtD
Goserelin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000346	0.000393	CcSEcCtD
Goserelin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00039	CcSEcCtD
Goserelin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000343	0.00039	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000343	0.00313	CbGpPWpGaD
Goserelin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000343	0.000389	CcSEcCtD
Goserelin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000389	CcSEcCtD
Goserelin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00034	0.000386	CcSEcCtD
Goserelin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000385	CcSEcCtD
Goserelin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000339	0.000385	CcSEcCtD
Goserelin—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000385	CcSEcCtD
Goserelin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000338	0.000384	CcSEcCtD
Goserelin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000383	CcSEcCtD
Goserelin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000381	CcSEcCtD
Goserelin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000335	0.000381	CcSEcCtD
Goserelin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.00038	CcSEcCtD
Goserelin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000334	0.00038	CcSEcCtD
Goserelin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000332	0.000377	CcSEcCtD
Goserelin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000332	0.000377	CcSEcCtD
Goserelin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000374	CcSEcCtD
Goserelin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000329	0.000374	CcSEcCtD
Goserelin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000329	0.000374	CcSEcCtD
Goserelin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000371	CcSEcCtD
Goserelin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000326	0.00037	CcSEcCtD
Goserelin—Pain—Etoposide—peripheral nervous system neoplasm	0.000326	0.00037	CcSEcCtD
Goserelin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000326	0.00037	CcSEcCtD
Goserelin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000369	CcSEcCtD
Goserelin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000367	CcSEcCtD
Goserelin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.000367	CcSEcCtD
Goserelin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000322	0.000366	CcSEcCtD
Goserelin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000365	CcSEcCtD
Goserelin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000365	CcSEcCtD
Goserelin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000363	CcSEcCtD
Goserelin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000361	CcSEcCtD
Goserelin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00036	CcSEcCtD
Goserelin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000359	CcSEcCtD
Goserelin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000357	CcSEcCtD
Goserelin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000314	0.000357	CcSEcCtD
Goserelin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000356	CcSEcCtD
Goserelin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000313	0.000356	CcSEcCtD
Goserelin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000354	CcSEcCtD
Goserelin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000312	0.000354	CcSEcCtD
Goserelin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000311	0.000354	CcSEcCtD
Goserelin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000353	CcSEcCtD
Goserelin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000352	CcSEcCtD
Goserelin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00035	CcSEcCtD
Goserelin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00035	CcSEcCtD
Goserelin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000307	0.000348	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000307	0.00281	CbGpPWpGaD
Goserelin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.000348	CcSEcCtD
Goserelin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000346	CcSEcCtD
Goserelin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000303	0.000344	CcSEcCtD
Goserelin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000344	CcSEcCtD
Goserelin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000343	CcSEcCtD
Goserelin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000343	CcSEcCtD
Goserelin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000302	0.000342	CcSEcCtD
Goserelin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000302	0.000342	CcSEcCtD
Goserelin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000342	CcSEcCtD
Goserelin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000342	CcSEcCtD
Goserelin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000342	CcSEcCtD
Goserelin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000299	0.00034	CcSEcCtD
Goserelin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000299	0.000339	CcSEcCtD
Goserelin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000339	CcSEcCtD
Goserelin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000338	CcSEcCtD
Goserelin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000338	CcSEcCtD
Goserelin—Rash—Vincristine—peripheral nervous system neoplasm	0.000297	0.000337	CcSEcCtD
Goserelin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000297	0.000337	CcSEcCtD
Goserelin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000337	CcSEcCtD
Goserelin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000336	CcSEcCtD
Goserelin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000335	CcSEcCtD
Goserelin—Headache—Vincristine—peripheral nervous system neoplasm	0.000295	0.000335	CcSEcCtD
Goserelin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000332	CcSEcCtD
Goserelin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000331	CcSEcCtD
Goserelin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00033	CcSEcCtD
Goserelin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000285	0.000324	CcSEcCtD
Goserelin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000319	CcSEcCtD
Goserelin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000281	0.000319	CcSEcCtD
Goserelin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000318	CcSEcCtD
Goserelin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00028	0.000318	CcSEcCtD
Goserelin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000317	CcSEcCtD
Goserelin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000317	CcSEcCtD
Goserelin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000316	CcSEcCtD
Goserelin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000316	CcSEcCtD
Goserelin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000314	CcSEcCtD
Goserelin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000312	CcSEcCtD
Goserelin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000312	CcSEcCtD
Goserelin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000274	0.000311	CcSEcCtD
Goserelin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000273	0.00031	CcSEcCtD
Goserelin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.00031	CcSEcCtD
Goserelin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000309	CcSEcCtD
Goserelin—Chills—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000307	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00027	0.00247	CbGpPWpGaD
Goserelin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00027	0.000307	CcSEcCtD
Goserelin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000305	CcSEcCtD
Goserelin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000302	CcSEcCtD
Goserelin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000301	CcSEcCtD
Goserelin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000299	CcSEcCtD
Goserelin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000263	0.000298	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000262	0.0024	CbGpPWpGaD
Goserelin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000262	0.000298	CcSEcCtD
Goserelin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000298	CcSEcCtD
Goserelin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000298	CcSEcCtD
Goserelin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000261	0.000296	CcSEcCtD
Goserelin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000296	CcSEcCtD
Goserelin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000294	CcSEcCtD
Goserelin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000293	CcSEcCtD
Goserelin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000292	CcSEcCtD
Goserelin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000289	CcSEcCtD
Goserelin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000288	CcSEcCtD
Goserelin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000287	CcSEcCtD
Goserelin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000252	0.000286	CcSEcCtD
Goserelin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000286	CcSEcCtD
Goserelin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000286	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00025	0.00229	CbGpPWpGaD
Goserelin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000284	CcSEcCtD
Goserelin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000283	CcSEcCtD
Goserelin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000247	0.000281	CcSEcCtD
Goserelin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000247	0.00028	CcSEcCtD
Goserelin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000279	CcSEcCtD
Goserelin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000277	CcSEcCtD
Goserelin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000276	CcSEcCtD
Goserelin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000243	0.000275	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000242	0.00222	CbGpPWpGaD
Goserelin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000275	CcSEcCtD
Goserelin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000275	CcSEcCtD
Goserelin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000275	CcSEcCtD
Goserelin—Rash—Etoposide—peripheral nervous system neoplasm	0.00024	0.000273	CcSEcCtD
Goserelin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00024	0.000273	CcSEcCtD
Goserelin—Headache—Etoposide—peripheral nervous system neoplasm	0.000239	0.000271	CcSEcCtD
Goserelin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000271	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000238	0.00218	CbGpPWpGaD
Goserelin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.00027	CcSEcCtD
Goserelin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000268	CcSEcCtD
Goserelin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000267	CcSEcCtD
Goserelin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000266	CcSEcCtD
Goserelin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000266	CcSEcCtD
Goserelin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000265	CcSEcCtD
Goserelin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000263	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000229	0.0021	CbGpPWpGaD
Goserelin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00026	CcSEcCtD
Goserelin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000259	CcSEcCtD
Goserelin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000258	CcSEcCtD
Goserelin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000227	0.000257	CcSEcCtD
Goserelin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000257	CcSEcCtD
Goserelin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000255	CcSEcCtD
Goserelin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000254	CcSEcCtD
Goserelin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000253	CcSEcCtD
Goserelin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000253	CcSEcCtD
Goserelin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000253	CcSEcCtD
Goserelin—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000252	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000252	CcSEcCtD
Goserelin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00022	0.00025	CcSEcCtD
Goserelin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000248	CcSEcCtD
Goserelin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000248	CcSEcCtD
Goserelin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000246	CcSEcCtD
Goserelin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000245	CcSEcCtD
Goserelin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000243	CcSEcCtD
Goserelin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000243	CcSEcCtD
Goserelin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000243	CcSEcCtD
Goserelin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000241	CcSEcCtD
Goserelin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00024	CcSEcCtD
Goserelin—Shock—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000239	CcSEcCtD
Goserelin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000239	CcSEcCtD
Goserelin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000238	CcSEcCtD
Goserelin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000238	CcSEcCtD
Goserelin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000238	CcSEcCtD
Goserelin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000237	CcSEcCtD
Goserelin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000236	CcSEcCtD
Goserelin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000235	CcSEcCtD
Goserelin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000234	CcSEcCtD
Goserelin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000234	CcSEcCtD
Goserelin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000234	CcSEcCtD
Goserelin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000234	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000233	CcSEcCtD
Goserelin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000232	CcSEcCtD
Goserelin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000231	CcSEcCtD
Goserelin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000229	CcSEcCtD
Goserelin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000227	CcSEcCtD
Goserelin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000227	CcSEcCtD
Goserelin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000225	CcSEcCtD
Goserelin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000225	CcSEcCtD
Goserelin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000223	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000221	CcSEcCtD
Goserelin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000221	CcSEcCtD
Goserelin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00022	CcSEcCtD
Goserelin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00022	CcSEcCtD
Goserelin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00022	CcSEcCtD
Goserelin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000219	CcSEcCtD
Goserelin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000218	CcSEcCtD
Goserelin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000218	CcSEcCtD
Goserelin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000217	CcSEcCtD
Goserelin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000217	CcSEcCtD
Goserelin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000216	CcSEcCtD
Goserelin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000214	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000188	0.00172	CbGpPWpGaD
Goserelin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000214	CcSEcCtD
Goserelin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000211	CcSEcCtD
Goserelin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00021	CcSEcCtD
Goserelin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000209	CcSEcCtD
Goserelin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000208	CcSEcCtD
Goserelin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000208	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000205	CcSEcCtD
Goserelin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000203	CcSEcCtD
Goserelin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000202	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000177	0.00162	CbGpPWpGaD
Goserelin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.0002	CcSEcCtD
Goserelin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000176	0.0002	CcSEcCtD
Goserelin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.0002	CcSEcCtD
Goserelin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000199	CcSEcCtD
Goserelin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000198	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000172	0.00158	CbGpPWpGaD
Goserelin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000195	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000171	0.00156	CbGpPWpGaD
Goserelin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000194	CcSEcCtD
Goserelin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000193	CcSEcCtD
Goserelin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000192	CcSEcCtD
Goserelin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000192	CcSEcCtD
Goserelin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000192	CcSEcCtD
Goserelin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000192	CcSEcCtD
Goserelin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000185	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000162	0.00148	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000184	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000159	0.00146	CbGpPWpGaD
Goserelin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000179	CcSEcCtD
Goserelin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000179	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000157	0.00143	CbGpPWpGaD
Goserelin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000178	CcSEcCtD
Goserelin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000178	CcSEcCtD
Goserelin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000174	CcSEcCtD
Goserelin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000172	CcSEcCtD
Goserelin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000166	CcSEcCtD
Goserelin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000166	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000143	0.00131	CbGpPWpGaD
Goserelin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000161	CcSEcCtD
Goserelin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000161	CcSEcCtD
Goserelin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000159	CcSEcCtD
Goserelin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000154	CcSEcCtD
Goserelin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000154	CcSEcCtD
Goserelin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000153	CcSEcCtD
Goserelin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000153	CcSEcCtD
Goserelin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000152	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000133	0.00122	CbGpPWpGaD
Goserelin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000149	CcSEcCtD
Goserelin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000144	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000126	0.00115	CbGpPWpGaD
Goserelin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000143	CcSEcCtD
Goserelin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000142	CcSEcCtD
Goserelin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000142	CcSEcCtD
Goserelin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000141	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000119	0.00109	CbGpPWpGaD
Goserelin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000133	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000115	0.00106	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000114	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.00011	0.001	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000105	0.000959	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000105	0.000958	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.59e-05	0.000877	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.25e-05	0.000846	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.93e-05	0.000817	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.33e-05	0.000671	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.01e-05	0.000641	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.19e-05	0.000566	CbGpPWpGaD
